Abstract
We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.
| Original language | English |
|---|---|
| Pages (from-to) | 180-191 |
| Number of pages | 12 |
| Journal | European Neuropsychopharmacology |
| Volume | 21 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 1 Feb 2011 |
Fingerprint
Keywords
- Care
- Cost
- Cost-of-illness
- Economic burden
- Europe
- Parkinson's Disease
Cite this
}
Costs of illness and care in Parkinson's Disease : An evaluation in six countries. / von Campenhausen, Sonja; Winter, Yaroslav; Rodrigues e Silva, Antonio; Sampaio, Christina; Ruzicka, Evzen; Barone, Paolo; Poewe, Werner; Guekht, Alla; Mateus, Céu; Pfeiffer, Karl P.; Berger, Karin; Skoupa, Jana; Bötzel, Kai; Geiger-Gritsch, Sabine; Siebert, Uwe; Balzer-Geldsetzer, Monika; Oertel, Wolfgang H.; Dodel, Richard; Reese, Jens P.
In: European Neuropsychopharmacology, Vol. 21, No. 2, 01.02.2011, p. 180-191.Research output: Contribution to journal › Article
TY - JOUR
T1 - Costs of illness and care in Parkinson's Disease
T2 - An evaluation in six countries
AU - von Campenhausen, Sonja
AU - Winter, Yaroslav
AU - Rodrigues e Silva, Antonio
AU - Sampaio, Christina
AU - Ruzicka, Evzen
AU - Barone, Paolo
AU - Poewe, Werner
AU - Guekht, Alla
AU - Mateus, Céu
AU - Pfeiffer, Karl P.
AU - Berger, Karin
AU - Skoupa, Jana
AU - Bötzel, Kai
AU - Geiger-Gritsch, Sabine
AU - Siebert, Uwe
AU - Balzer-Geldsetzer, Monika
AU - Oertel, Wolfgang H.
AU - Dodel, Richard
AU - Reese, Jens P.
PY - 2011/2/1
Y1 - 2011/2/1
N2 - We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.
AB - We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.
KW - Care
KW - Cost
KW - Cost-of-illness
KW - Economic burden
KW - Europe
KW - Parkinson's Disease
UR - http://www.scopus.com/inward/record.url?scp=78751624162&partnerID=8YFLogxK
U2 - 10.1016/j.euroneuro.2010.08.002
DO - 10.1016/j.euroneuro.2010.08.002
M3 - Article
VL - 21
SP - 180
EP - 191
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
SN - 0924-977X
IS - 2
ER -